Schrodinger, Inc. (NASDAQ:SDGR) Given Consensus Rating of “Hold” by Analysts

Shares of Schrodinger, Inc. (NASDAQ:SDGR) have been assigned an average rating of “Hold” from the seven ratings firms that are currently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $26.00.

A number of research firms recently weighed in on SDGR. Wall Street Zen raised Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, October 25th. The Goldman Sachs Group began coverage on Schrodinger in a research note on Monday, September 29th. They issued a “neutral” rating and a $19.00 target price on the stock. Weiss Ratings restated a “sell (e+)” rating on shares of Schrodinger in a report on Tuesday, October 14th. Morgan Stanley lowered their price target on Schrodinger from $28.00 to $19.00 and set an “equal weight” rating for the company in a research report on Monday, August 18th. Finally, Barclays assumed coverage on shares of Schrodinger in a research report on Thursday, August 14th. They set an “overweight” rating and a $25.00 price objective on the stock.

Schrodinger Price Performance

Shares of Schrodinger stock opened at $17.42 on Friday. Schrodinger has a 1 year low of $15.99 and a 1 year high of $28.47. The firm has a market cap of $1.28 billion, a price-to-earnings ratio of -7.23 and a beta of 1.77. The company has a 50-day moving average of $19.49 and a 200 day moving average of $20.46.

Schrodinger (NASDAQ:SDGR) last posted its quarterly earnings data on Wednesday, November 5th. The company reported ($0.45) EPS for the quarter, topping the consensus estimate of ($0.72) by $0.27. Schrodinger had a negative net margin of 68.49% and a negative return on equity of 48.24%. The business had revenue of $54.32 million for the quarter, compared to analyst estimates of $50.51 million. During the same quarter in the previous year, the firm posted ($0.87) earnings per share. Schrodinger’s quarterly revenue was up 53.9% on a year-over-year basis. Schrodinger has set its FY 2025 guidance at EPS. On average, equities analysts anticipate that Schrodinger will post -2.37 EPS for the current year.

Insider Activity

In other news, insider Margaret Dugan sold 1,395 shares of the stock in a transaction that occurred on Thursday, October 16th. The shares were sold at an average price of $21.07, for a total transaction of $29,392.65. Following the sale, the insider owned 24,574 shares in the company, valued at $517,774.18. This represents a 5.37% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Corporate insiders own 21.00% of the company’s stock.

Hedge Funds Weigh In On Schrodinger

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. CANADA LIFE ASSURANCE Co increased its holdings in shares of Schrodinger by 4.7% in the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 66,520 shares of the company’s stock worth $1,332,000 after purchasing an additional 2,995 shares in the last quarter. PharVision Advisers LLC purchased a new stake in shares of Schrodinger during the third quarter valued at $286,000. XTX Topco Ltd increased its holdings in Schrodinger by 82.2% in the 3rd quarter. XTX Topco Ltd now owns 53,596 shares of the company’s stock worth $1,075,000 after buying an additional 24,172 shares in the last quarter. Verity Asset Management Inc. increased its holdings in Schrodinger by 43.5% in the 3rd quarter. Verity Asset Management Inc. now owns 64,924 shares of the company’s stock worth $1,302,000 after buying an additional 19,673 shares in the last quarter. Finally, Quarry LP raised its position in Schrodinger by 73.6% in the 3rd quarter. Quarry LP now owns 2,401 shares of the company’s stock worth $48,000 after buying an additional 1,018 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

About Schrodinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.